Allspring Global Investments’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Allspring Global Investments's BIIB Position: Q1 2026 in Review
Allspring Global Investments increased its Biogen (BIIB) stake by 0.49% in Q1 2026, buying an estimated $6.63K and bringing the position to 7,322 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1118.
Allspring Global Investments first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. The position peaked at $27.9M in Q4 2022. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Allspring Global Investments held 7,322 shares of Biogen worth $1.35M as of Q1 2026.
- Allspring Global Investments bought 36 Biogen shares in Q1 2026, an estimated $6.63K.
- Biogen made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1118 holding.
- Allspring Global Investments first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Biogen position peaked at $27.9M in Q4 2022.
- 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.